Cargando…
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
OBJECTIVES: During the COVID-19 pandemic, SARS-CoV-2 antibody testing has been suggested for (1) screening populations for disease prevalence, (2) diagnostics, and (3) guiding therapeutic applications. Here, we conducted a detailed clinical evaluation of four Anti-SARS-CoV-2 immunoassays in samples...
Autores principales: | Buchholtz, Marie-Luise, Arend, Florian M., Eichhorn, Peter, Weigand, Michael, Kleinhempel, Alisa, Häusler, Kurt, Bruegel, Mathias, Holdt, Lesca M., Teupser, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118560/ https://www.ncbi.nlm.nih.gov/pubmed/33984048 http://dx.doi.org/10.1371/journal.pone.0251587 |
Ejemplares similares
-
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
por: Geyer, Philipp E, et al.
Publicado: (2021) -
Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
por: Geyer, Philipp E, et al.
Publicado: (2019) -
From genotype to phenotype in human atherosclerosis - recent findings
por: Holdt, Lesca M., et al.
Publicado: (2013) -
Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis
por: Holdt, Lesca M., et al.
Publicado: (2018) -
Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study
por: Zoller, Michael, et al.
Publicado: (2014)